The DDF is supported by a broad and influential group of strategic investors.

The DDF represents the first time that charity, government and the pharmaceutical industry have joined together on this scale with a venture capital firm with the combined aim of tackling a major global health issue.

Since 1993, SV Health Investors has created and/or funded over 175 life sciences companies in the US and EU, working collaboratively with universities, academic institutes and the biotechnology/pharmaceutical industry. We have a proven record discovering and developing new drugs, many of which are now in routine clinical use and are helping patients every day across a range of indications.


Our investors include a broad mix of charities, government bodies and pharmaceutical companies